Eli Lilly will invest over $1 billion in India to establish new contract manufacturing facilities and a manufacturing and quality hub in Hyderabad. This significant investment aims to strengthen ...

US pharmaceutical company Eli Lilly and Company plans to invest over $1 billion in India over the next few years to set up new contract manufacturing facilities and a manufacturing and quality hub in ...

US pharmaceutical giant Eli Lilly, best known for its blockbuster weight-loss drug Mounjaro, is set to pour over $1 billion (Rs 8,900 crore) into India over the next few years. The company plans to ...

Industry experts and policymakers are of the view that India’s homoeopathic sector is rapidly evolving into a global hub for high-quality, science-backed natural medicines by combining traditional ...

India is on the path to becoming a global powerhouse in clinical research, driven by transformative advancements across the healthcare landscape. With a richly diverse population, a highly skilled ...

India's homoeopathic sector is rapidly becoming a global leader, thanks to advanced technology, strict quality norms, and government support. Initiatives like Make in India and the National AYUSH ...

Eli Lilly will invest over $1 billion in India to establish new contract manufacturing facilities and a manufacturing and quality hub in Hyderabad. This significant investment aims to strengthen ...